26 January 2023
10.00-10.30:  Registration & Welcome coffee
10.30-10.45:  Welcome address by Dr. Ulf Nehrbass, CEO of Luxembourg Institute of Health, and the organizers
10.45-11.30:  Keynote 1: Prof. Veerle Baekelandt, KU Leuven, BE. Unraveling the role of alpha-synuclein aggregation in Parkinson’s disease and related disorders
Session 1: Cohorts and Clinical Phenotypes, Chair: Prof. Dr. Thomas Klockgether

11.30-11.50:  Prof. Asha Kishore, Medcity, Kochi, IN. Clinical and environmental risk factors of PD: interim observations of GAP-India

11.50-12.10:  Prof. Thomas Gasser, Hertie-Institute for Clinical Brain Research University of Tübingen, GER. Genetic risk and resilience in Parkinson’s disease

12.10-12.20:  Prof. Jean-Christophe Corvol, Paris Brain Institute, FR. The value of nation-wide patient cohorts for impact for clinical care

12.20-12.30:  FNR Funding agency flash presentation

12.30-13.30:  Walking lunch with exhibition and poster session

Session 2: PD Genetics and genomics, Chair: Prof. Asha Kishore 

13.30-13.50:  Prof. Enza Maria Valente, University of Pavia, IT. Understanding the mitochondrial phenotype of PD and its impact for precision medicine

13.50-14.10:  Prof. Soraya Bardien, Stellenbosch University, SA. Genetics of PD in Sub-Saharan Africa: What do we know?
14.10-14.30:  Dr. Patrick May, LCSB, University of Luxembourg, LU. Genetic risk prediction in PD

14.30-14.45:  Young scientist presentations

Session 3: Parkinson’s disease and Cognition – from risk factors to prevention, Chair: Prof. Dr. Ullrich Wüllner 
14.45-15.05:   Prof. Pille Taba, University of Tartu, ES. Parkinson’s disease and Cognition – from risk factors to prevention

15.05-15.25:   Prof. Anja Leist, University of Luxembourg, LU. Modifiable risk factors in dementia prevention

15.25-15.45:   Prof. Andrew Singleton, National Institute of Aging, US. Dissecting PD genetics worldwide – the GP2 initiative

15.45-16.00:   Young scientist presentations

16.00-16.30:   Coffee break with exhibition and poster session
Session 4: Genetics stratification for precision medicine, Chair: Dr. Brit Mollenhauer   

16.30-16.50:    Prof. Pramod Pal, National Institute of Mental Health and Neurosciences, IN. Impulse Control Disorders in PD

16.50-17.10:    Prof. Rupam Borgohain, Nizam’s Institute of Medical Sciences, IN. Deep Brain Stimulation in India

17.10-17.30:    Dr. Kathrin Brockmann, University Tübingen, GER. Lessons learned from GBA stratification for treatment and prediction

17.30-17.45:    Young scientist presentations

17.45-18.00:    Wrap up


27 January 2023

8.30-8.45:     Welcome coffee
8.45-9.00:     Welcome address by Prof. Dr. Michael Heneka, Director of LCSB

9.00-9.45:     Keynote 2: Prof. Caroline Tanner, University of California San Francisco, USA. Epidemiology, Targeting Parkinson’s Disease Prevention: from Population Studies to Precision Medicine

Session 5: From cellular mechanisms to novel biomarkers, Chair: Prof. Jochen Roeper 

9.45-10.05:    Dr. Brit Mollenhauer, Paracelsus-Elena Klinik, GER. Toward biomarkers for prevention trials in Parkinson’s disease

10.05-10.25:  Prof. Pankaj Seth, National Brain Research Center Manesar, IN. A primary cell culture model of human brain cells for understanding neurodegenerative diseases

10.25-10.45:  Coffee break with exhibition and poster session

10.45-11.05:  Prof. Anne Grünewald, LCSB, University Luxembourg, LU. Cellular models for PD

11.05-11.20:  Young scientist presentations

Session 6: Data Management and Bioinformatics Analysis, Chair: Dr. Reinhard Schneider

11.20-11.40:  Dr. Jens Krüger, University Tübingen, GER.

11.40-12.00:  Dr. Venkata Satagopam, LCSB, University Luxembourg, LU. Developing an EU hub for at risk cohorts

12.00-12.45:  Keynote 3: Prof. Nobutaka Hattori, RIKEN Center for Brain Science, Saitama, Japan.
12.45-13.15:  Funding agencies flash presentation DFG, MJFF & DBT/DST

13.15-14.15:  Lunch + Young scientist presentations

14.15-14.20:  Wrap up